• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TIGIT标记耗竭的T细胞,并作为慢性HBV感染患者免疫恢复的靶点。

TIGIT marks exhausted T cells and serves as a target for immune restoration in patients with chronic HBV infection.

作者信息

Wei Yan-Yan, Fan Jing, Shan Meng-Xuan, Yin Dan-Dan, Wang Li-Li, Ye Wei, Zhao Wei

机构信息

Department of Infectious Disease, The First Affiliated Hospital of Anhui Medical University Hefei 230022, Anhui, China.

Department of Clinical Research Center, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine Nanjing 210003, Jiangsu, China.

出版信息

Am J Transl Res. 2022 Feb 15;14(2):942-954. eCollection 2022.

PMID:35273697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8902551/
Abstract

BACKGROUND

Chronic HBV infection is a serious worldwide health problem that mainly causes liver cirrhosis and hepatocellular carcinoma (HCC). Few studies have explored how T cell exhaustion helps HBV avoid immune system attack and how to reverse that exhaustion. Recently, T cell immunoglobulin and immune receptor tyrosine-based inhibitory motif (ITIM) domain (TIGIT) have been identified as coinhibitory receptors, similar to PD-1. This study explores the expression of TIGIT and the T cell function changes in patients with chronic HBV infection.

RESULTS

In this study, we found that the expression of TIGIT on T cells increased significantly in patients with chronic HBV infection. High expression of TIGIT on T cells is associated with functional exhaustion. Importantly, this study demonstrates that blocking TIGIT can reverse T cell exhaustion and restore function in patients with chronic HBV infection.

CONCLUSIONS

HBV induces T cell exhaustion by up-regulating the expression of TIGIT. Blocking the TIGIT/PVR signaling pathway can reverse T cell exhaustion, so this discovery provides an immunotherapy target to battle chronic HBV infection.

摘要

背景

慢性乙型肝炎病毒(HBV)感染是一个严重的全球性健康问题,主要导致肝硬化和肝细胞癌(HCC)。很少有研究探讨T细胞耗竭如何帮助HBV逃避免疫系统攻击以及如何逆转这种耗竭。最近,T细胞免疫球蛋白和基于免疫受体酪氨酸的抑制基序(ITIM)结构域(TIGIT)已被鉴定为共抑制受体,类似于程序性死亡受体1(PD-1)。本研究探讨慢性HBV感染患者中TIGIT的表达及T细胞功能变化。

结果

在本研究中,我们发现慢性HBV感染患者T细胞上TIGIT的表达显著增加。T细胞上TIGIT的高表达与功能耗竭相关。重要的是,本研究表明阻断TIGIT可逆转慢性HBV感染患者的T细胞耗竭并恢复其功能。

结论

HBV通过上调TIGIT的表达诱导T细胞耗竭。阻断TIGIT/脊髓灰质炎病毒受体(PVR)信号通路可逆转T细胞耗竭,因此这一发现为对抗慢性HBV感染提供了一个免疫治疗靶点。

相似文献

1
TIGIT marks exhausted T cells and serves as a target for immune restoration in patients with chronic HBV infection.TIGIT标记耗竭的T细胞,并作为慢性HBV感染患者免疫恢复的靶点。
Am J Transl Res. 2022 Feb 15;14(2):942-954. eCollection 2022.
2
PD-1 TIGIT CD8 T cells are associated with pathogenesis and progression of patients with hepatitis B virus-related hepatocellular carcinoma.PD-1/TIGIT/CD8 T 细胞与乙型肝炎病毒相关肝细胞癌患者的发病机制和进展相关。
Cancer Immunol Immunother. 2019 Dec;68(12):2041-2054. doi: 10.1007/s00262-019-02426-5. Epub 2019 Nov 12.
3
Immune Exhaustion of T Cells in Alveolar Echinococcosis Patients and Its Reversal by Blocking Checkpoint Receptor TIGIT in a Murine Model.肺泡型包虫病患者 T 细胞免疫耗竭及其在小鼠模型中通过阻断检查点受体 TIGIT 的逆转。
Hepatology. 2020 Apr;71(4):1297-1315. doi: 10.1002/hep.30896. Epub 2020 Jan 24.
4
Blockade of T-cell receptor with Ig and ITIM domains elicits potent antitumor immunity in naturally occurring HBV-related HCC in mice.用含免疫球蛋白和免疫受体酪氨酸抑制基序结构域的分子阻断T细胞受体,可在小鼠自然发生的乙型肝炎病毒相关肝癌中引发强大的抗肿瘤免疫。
Hepatology. 2023 Mar 1;77(3):965-981. doi: 10.1002/hep.32715. Epub 2023 Feb 17.
5
Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia.在急性髓系白血病患者中,Blimp-1通过上调TIGIT和PD-1来损害T细胞功能。
J Hematol Oncol. 2017 Jun 19;10(1):124. doi: 10.1186/s13045-017-0486-z.
6
TIGIT TIM-3 NK cells are correlated with NK cell exhaustion and disease progression in patients with hepatitis B virus‑related hepatocellular carcinoma.TIGIT/TIM-3+NK 细胞与乙型肝炎病毒相关肝细胞癌患者 NK 细胞耗竭和疾病进展相关。
Oncoimmunology. 2021 Jun 28;10(1):1942673. doi: 10.1080/2162402X.2021.1942673. eCollection 2021.
7
T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8+ T-Cell Exhaustion and Poor Clinical Outcome in AML Patients.T 细胞免疫球蛋白和内含 ITIM 结构域(TIGIT)与 AML 患者 CD8+ T 细胞耗竭和不良临床结局相关。
Clin Cancer Res. 2016 Jun 15;22(12):3057-66. doi: 10.1158/1078-0432.CCR-15-2626. Epub 2016 Jan 13.
8
TIGIT Signaling Pathway Regulates Natural Killer Cell Function in Chronic Hepatitis B Virus Infection.TIGIT信号通路在慢性乙型肝炎病毒感染中调节自然杀伤细胞功能。
Front Med (Lausanne). 2022 Feb 21;8:816474. doi: 10.3389/fmed.2021.816474. eCollection 2021.
9
Targeting TIGIT for cancer immunotherapy: recent advances and future directions.靶向TIGIT进行癌症免疫治疗:最新进展与未来方向
Biomark Res. 2024 Jan 16;12(1):7. doi: 10.1186/s40364-023-00543-z.
10
Involvement of TIGIT in Natural Killer Cell Exhaustion and Immune Escape in Patients and Mouse Model With Liver Echinococcus multilocularis Infection.TIGIT 在肝泡型包虫病患者和小鼠模型自然杀伤细胞耗竭及免疫逃逸中的作用
Hepatology. 2021 Dec;74(6):3376-3393. doi: 10.1002/hep.32035. Epub 2021 Sep 28.

引用本文的文献

1
Anti-PD-1 therapy achieves favorable outcome in gastric cancer combined with chronic hepatitis B.抗程序性死亡蛋白1(PD-1)疗法在合并慢性乙型肝炎的胃癌患者中取得了良好疗效。
BMC Cancer. 2025 Aug 22;25(1):1354. doi: 10.1186/s12885-025-14776-8.
2
Early expansion of TIGIT+PD1+ effector memory CD4 T cells via agonistic effect of alefacept in new-onset type 1 diabetes.通过阿法赛特的激动作用,新发1型糖尿病中TIGIT+PD1+效应记忆CD4 T细胞的早期扩增
J Immunol. 2025 Jan 1;214(1):12-22. doi: 10.1093/jimmun/vkae014.
3
Liver sinusoidal endothelial cells regulate the balance between hepatic immunosuppression and immunosurveillance.肝窦内皮细胞调节肝脏免疫抑制和免疫监视之间的平衡。
Front Immunol. 2025 Jan 17;15:1497788. doi: 10.3389/fimmu.2024.1497788. eCollection 2024.
4
A Systematic Review of the Advances in the Study of T Lymphocyte Suppressor Receptors in HBV Infection: Potential Therapeutic Targets.乙型肝炎病毒感染中T淋巴细胞抑制受体研究进展的系统综述:潜在治疗靶点
J Clin Med. 2024 Feb 21;13(5):1210. doi: 10.3390/jcm13051210.
5
T cell specific deletion of Casitas B lineage lymphoma-b reduces atherosclerosis, but increases plaque T cell infiltration and systemic T cell activation.T 细胞特异性敲除 Casitas B 细胞淋巴瘤-b 可减少动脉粥样硬化,但增加斑块 T 细胞浸润和全身 T 细胞活化。
Front Immunol. 2024 Mar 4;15:1297893. doi: 10.3389/fimmu.2024.1297893. eCollection 2024.
6
Advances in Immunotherapy for Hepatocellular Carcinoma (HCC).肝癌免疫治疗的进展。
Curr Oncol. 2023 Nov 7;30(11):9789-9812. doi: 10.3390/curroncol30110711.
7
CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma.CD8 效应 T 细胞增强了 BCMA 暴露和未暴露的多发性骨髓瘤患者对 teclistamab 的反应。
Blood Adv. 2024 Apr 9;8(7):1600-1611. doi: 10.1182/bloodadvances.2023011225.
8
Recent advances in understanding T cell activation and exhaustion during HBV infection.乙型肝炎病毒感染过程中 T 细胞激活和耗竭的研究进展。
Virol Sin. 2023 Dec;38(6):851-859. doi: 10.1016/j.virs.2023.10.007. Epub 2023 Oct 21.
9
Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients.单细胞RNA分析揭示了嵌合抗原受体T细胞的细胞内在功能,这些功能与淋巴瘤患者II期研究中的反应相关。
Clin Cancer Res. 2023 Oct 13;29(20):4139-4152. doi: 10.1158/1078-0432.CCR-23-0178.
10
Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation.HBV 感染背景下的 T 细胞和 NK 细胞免疫检查点:全景、病理生理学和治疗开发。
Front Immunol. 2023 Mar 28;14:1148111. doi: 10.3389/fimmu.2023.1148111. eCollection 2023.

本文引用的文献

1
T cell immune discriminants of HIV reservoir size in a pediatric cohort of perinatally infected individuals.T 细胞免疫标志物可预测儿童围生期感染个体 HIV 储存库大小。
PLoS Pathog. 2021 Apr 26;17(4):e1009533. doi: 10.1371/journal.ppat.1009533. eCollection 2021 Apr.
2
TIGIT signaling restores suppressor function of Th1 Tregs.TIGIT信号传导可恢复Th1调节性T细胞的抑制功能。
JCI Insight. 2019 Feb 7;4(3):e124427. doi: 10.1172/jci.insight.124427.
3
Breakdown of adaptive immunotolerance induces hepatocellular carcinoma in HBsAg-tg mice.适应性免疫耐受的崩溃导致 HBsAg-tg 小鼠发生肝细胞癌。
Nat Commun. 2019 Jan 15;10(1):221. doi: 10.1038/s41467-018-08096-8.
4
Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update).《慢性乙型肝炎防治指南(2015年版)》
J Clin Transl Hepatol. 2017 Dec 28;5(4):297-318. doi: 10.14218/JCTH.2016.00019. Epub 2017 Nov 12.
5
Programmed Cell Death 1 (PD-1) and Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Viral Hepatitis.程序性细胞死亡蛋白 1(PD-1)和细胞毒性 T 淋巴细胞相关抗原 4(CTLA-4)在病毒性肝炎中的作用。
Int J Mol Sci. 2017 Jul 13;18(7):1517. doi: 10.3390/ijms18071517.
6
PD-1 Blockade Promotes Emerging Checkpoint Inhibitors in Enhancing T Cell Responses to Allogeneic Dendritic Cells.程序性死亡蛋白1(PD-1)阻断促进新型检查点抑制剂增强T细胞对同种异体树突状细胞的反应。
Front Immunol. 2017 May 22;8:572. doi: 10.3389/fimmu.2017.00572. eCollection 2017.
7
Early and Delayed Antiretroviral Therapy Results in Comparable Reductions in CD8 T Cell Exhaustion Marker Expression.早期和延迟抗逆转录病毒疗法导致CD8 T细胞耗竭标志物表达的降低程度相当。
AIDS Res Hum Retroviruses. 2017 Jul;33(7):658-667. doi: 10.1089/AID.2016.0324. Epub 2017 Apr 25.
8
Inflammatory cytokines compromise programmed cell death-1 (PD-1)-mediated T cell suppression in inflammatory arthritis through up-regulation of soluble PD-1.炎性细胞因子通过上调可溶性程序性细胞死亡蛋白1(PD-1),损害炎性关节炎中PD-1介导的T细胞抑制作用。
Clin Exp Immunol. 2017 Jun;188(3):455-466. doi: 10.1111/cei.12949. Epub 2017 Apr 3.
9
The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy.免疫疗法在结直肠癌中的潜在价值:程序性死亡-1抑制剂治疗的证据综述
Clin Colorectal Cancer. 2016 Dec;15(4):285-291. doi: 10.1016/j.clcc.2016.07.007. Epub 2016 Jul 22.
10
CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART.表达程序性死亡受体1(PD-1)、T细胞免疫球蛋白和ITIM结构域(TIGIT)以及淋巴细胞激活基因3(LAG-3)的CD4+ T细胞在抗逆转录病毒治疗期间导致HIV持续存在。
PLoS Pathog. 2016 Jul 14;12(7):e1005761. doi: 10.1371/journal.ppat.1005761. eCollection 2016 Jul.